Page last updated: 2024-10-24

carprofen and Cancer of Head

carprofen has been researched along with Cancer of Head in 2 studies

carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.

Research Excerpts

ExcerptRelevanceReference
"Patients with epidermoid cancer of the head and neck thus have an abnormality of immunoregulatory monocytes that can contribute significantly to their depression of cellular immunity by elaborating prostaglandin E2."1.26Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. ( Balch, CM; Dougherty, PA; Tilden, AB, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balch, CM1
Dougherty, PA1
Tilden, AB1
McCormick, KJ1
Panje, WR1

Other Studies

2 other studies available for carprofen and Cancer of Head

ArticleYear
Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
    Annals of surgery, 1982, Volume: 196, Issue:6

    Topics: Adult; Aged; Carbazoles; Carcinoma, Squamous Cell; Dinoprostone; Head and Neck Neoplasms; Humans; In

1982
Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.
    Cancer immunology, immunotherapy : CII, 1986, Volume: 21, Issue:3

    Topics: Adult; Aged; Carbazoles; Carcinoma, Squamous Cell; Dinoprostone; Esterases; Head and Neck Neoplasms;

1986